Literature DB >> 2976077

The antigen-major histocompatibility complex-T cell receptor interaction. A structural analysis.

W V Williams1, D B Weiner, S Wadsworth, M I Greene.   

Abstract

In summary, we wish to propose that regions on MHC molecules interact with complementary regions on processed peptide antigens, and that the resultant Ag-MHC complex forms a conformation with separate functional regions that are able to interact with similarly complementary areas on T cell receptors. It is the product of these interactions that determines whether a given peptide Ag is capable of binding the MHC molecule, and whether a given Ag-MHC complex is capable of stimulating a particular T cell. As more becomes known about the molecular aspects of MHC-restricted, Ag-specific T cell activation, it will become clear which amino acid residues on the Ag, MHC, and TCR are involved in these interactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976077     DOI: 10.1007/bf02935538

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  50 in total

1.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

2.  Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor.

Authors:  L E Samelson; M D Patel; A M Weissman; J B Harford; R D Klausner
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

3.  Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochromes c with the use of synthetic peptide antigens.

Authors:  B S Fox; C Chen; E Fraga; C A French; B Singh; R H Schwartz
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

4.  H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.

Authors:  J L Maryanski; P Pala; G Corradin; B R Jordan; J C Cerottini
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

5.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

6.  Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.

Authors:  S M Hedrick; D I Cohen; E A Nielsen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

7.  Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins.

Authors:  S M Hedrick; E A Nielsen; J Kavaler; D I Cohen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

8.  Mouse T cell antigen receptor: structure and organization of constant and joining gene segments encoding the beta polypeptide.

Authors:  M Malissen; K Minard; S Mjolsness; M Kronenberg; J Goverman; T Hunkapiller; M B Prystowsky; Y Yoshikai; F Fitch; T W Mak
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

9.  Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes.

Authors:  S C Meuer; D A Cooper; J C Hodgdon; R E Hussey; K A Fitzgerald; S F Schlossman; E L Reinherz
Journal:  Science       Date:  1983-12-16       Impact factor: 47.728

10.  Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins. Implications for the mechanisms underlying major histocompatibility complex-restricted antigen recognition and clonal deletion models of immune response gene defects.

Authors:  N Shastri; A Oki; A Miller; E E Sercarz
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  1 in total

1.  Modulation of T cell responses with MHC-derived peptides.

Authors:  W V Williams; D B Weiner; M A Borofsky; D H Rubin; K Yui; M I Greene
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.